Lung Cancer Clinical Trial
Official title:
Retrospective Epidemiological Study of Lung Cancer With Low-dose Multislice Computed Tomography (LDCT) - a Screening Program
Lung cancer is one of the leading causes of cancer-related death in Taiwan. Early diagnosis
of lung cancer may improve cancer survival. Low-dose computed tomography (LDCT) was thought
to be the best screening tool for lung cancer. However, there is growing concerns about
radiation exposure, high cost, and high rate of false-positive screening result. Epidemiology
data for LDCT screening in Taiwan is lacking.
National Taiwan University Hospital Chu-Tung Branch (NTUHCT) initiated the lung cancer
screening by LDCT since June 2015. Many people can get the LDCT screening with affordable
price with the subsidy from enterprise donation. The purpose of this study is establishing
local epidemiological result via telephone follow-up and patients' medical records
retrospectively.
Lung cancer is one of the leading causes of cancer-related death in Taiwan. Early diagnosis
of lung cancer may improve cancer survival. Low-dose computed tomography (LDCT) was thought
to be the best screening tool for lung cancer. However, there is growing concerns about
radiation exposure, high cost, and high rate of false-positive screening result. Epidemiology
data for LDCT screening in Taiwan is lacking.
National Taiwan University Hospital Chu-Tung Branch (NTUHCT) initiated the lung cancer
screening by LDCT since June 2015. Many people can get the LDCT screening with affordable
price with the subsidy from enterprise donation. The purpose of this study is establishing
local epidemiological result via telephone follow-up and patients' medical records
retrospectively.
Aim: To establish the local epidemiological data for lung pathology, emphysema,
bronchiectasis and other lung disease.
Methods: Since June 2015, more than 6000 LDCT were done at the NTUHCT. Roughly 6 months after
the test telephone follow-ups about patient satisfactions, self-awareness of CT results,
medical consultations and other related behaviors, and willingness of coming back for another
test were routinely done. Retrospective secondary data analysis will be performed on the
telephone follow-up results to establish local epidemiology data on lung pathology as well as
information on screening accuracy of LDCT. Customers are also queried about willingness to
provide their medical records, and linkage to National Health Insurance Database with
informed consents to provide more advanced information on their long-term outcomes.
Keywords: Lung cancer, Low dose computed tomography, screening.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03918538 -
A Series of Study in Testing Efficacy of Pulmonary Rehabilitation Interventions in Lung Cancer Survivors
|
N/A | |
| Recruiting |
NCT05078918 -
Comprehensive Care Program for Their Return to Normal Life Among Lung Cancer Survivors
|
N/A | |
| Active, not recruiting |
NCT04548830 -
Safety of Lung Cryobiopsy in People With Cancer
|
Phase 2 | |
| Completed |
NCT04633850 -
Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients
|
||
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05583916 -
Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery
|
N/A | |
| Completed |
NCT00341939 -
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
|
||
| Not yet recruiting |
NCT06376253 -
A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers
|
Phase 1 | |
| Recruiting |
NCT05898594 -
Lung Cancer Screening in High-risk Black Women
|
N/A | |
| Active, not recruiting |
NCT05060432 -
Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT03575793 -
A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT03667716 -
COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.
|
Phase 1 | |
| Terminated |
NCT01624090 -
Mithramycin for Lung, Esophagus, and Other Chest Cancers
|
Phase 2 | |
| Terminated |
NCT03275688 -
NanoSpectrometer Biomarker Discovery and Confirmation Study
|
||
| Not yet recruiting |
NCT04931420 -
Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels
|
Phase 2 | |
| Recruiting |
NCT06010862 -
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors
|
Phase 1 | |
| Recruiting |
NCT06052449 -
Assessing Social Determinants of Health to Increase Cancer Screening
|
N/A | |
| Not yet recruiting |
NCT06017271 -
Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer
|
||
| Recruiting |
NCT05787522 -
Efficacy and Safety of AI-assisted Radiotherapy Contouring Software for Thoracic Organs at Risk
|